1969The Journal of ImmunologyRequires access

The Enhancement of Antibody Formation by Escherichia Coli Lipopolysaccharide and Detoxified Derivatives

Jay R. Schenck, Martha P. Hargie, Mickey S. Brown, Donna S. Ebert, Agnes L. Yoo, Floyd C. McIntire

Open publisher page 50 citations

Abstract

Summary The formation of antibody to human serum albumin (HSA) in rats was greatly enhanced when the protein was linked covalently to E. coli lipopolysaccharide (LPS). The response was less when HSA and LPS were only mixed before injection and nil when they were injected at separate sites subcutaneously. In rats the adjuvant effect of coupling LPS to HSA was comparable to that of using Freund's adjuvant or alum precipitation. In rabbits Freund's adjuvant was significantly the more effective. By the use of two qualitatively different detoxified derivatives, an adjuvant effect approximately equal to that of LPS was obtained with 1000-fold less pyrogenicity. The data suggest that LPS enhances antibody formation by acting directly upon the cells which respond to antigen, and possibly at the antigen-sensitive sites. In this effect both the lipid and polysaceharide portions of LPS appear to play a role, with lipid being the more important.

About this research paper

What this paper is about

Summary The formation of antibody to human serum albumin (HSA) in rats was greatly enhanced when the protein was linked covalently to E. coli lipopolysaccharide (LPS). The response was less when HSA and LPS were only mixed before injection and nil when they were injected at separate sites subcutaneously. In rats the adjuvant effect of coupling LPS to HSA was comparable to that of using Freund's adjuvant or alum precipitation. In rabbits Freund's adjuvant was significantly the more effective. By the use of two qualitatively different detoxified derivatives, an adjuvant effect approximately equal to that of LPS was obtained with 1000-fold less pyrogenicity. The data suggest that LPS enhances antibody formation by acting directly upon the cells which respond to antigen, and possibly at the antigen-sensitive sites. In this effect both the lipid and polysaceharide portions of LPS appear to play a role, with lipid being the more important.

Why it matters

OpenAlex reports 50 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Summary The formation of antibody to human serum albumin (HSA) in rats was greatly enhanced when the protein was linked covalently to E. coli lipopolysaccharide (LPS). The response was less when HSA and LPS were only mixed before injection and nil when they were injected at separate sites subcutaneously. In rats the adjuvant effect of coupling LPS to HSA was comparable to that of using Freund's adjuvant or alum precipitation. In rabbits Freund's adjuvant was significantly the more effective. By the use of two qualitatively different detoxified derivatives, an adjuvant effect approximately equal to that of LPS was obtained with 1000-fold less pyrogenicity. The data suggest that LPS enhances antibody formation by acting directly upon the cells which respond to antigen, and possibly at the antigen-sensitive sites. In this effect both the lipid and polysaceharide portions of LPS appear to play a role, with lipid being the more important.

Key concepts: Lipopolysaccharide, Adjuvant, Lipid A, Antigen, Antibody, Chemistry, Escherichia coli, Antibody response

Related papers

Back to paper searchBrowse research topicsOriginal source
The Enhancement of Antibody Formation by Escherichia Coli Lipopolysaccharide and Detoxified Derivatives — Research Paper | ScholarLens